Enter Title

CDC Meaningful Use Webinars

As part of Stage 2 Meaningful Use (MU), Eligible Professionals (EPs) can now choose “Cancer Reporting” as a public health reporting objective to receive incentives from the Centers for Medicare and Medicaid (CMS) to implement certified electronic health record (EHR) systems to report cancer data to state cancer registries. The Centers for Disease Control and Prevention (CDC) will host several MU Town Hall webinars to provide the cancer community with information, guidance, and technical assistance with implementation of Cancer Reporting in Meaningful Use (MU) Stage 2. Recordings and associated documents from past webinars can be found below.

Meaningful Use Town Hall 5 - December 17, 2013

The Centers for Disease Control and Prevention (CDC) invites you to participate in a Cancer Reporting Meaningful Use (MU) Town Hall Meeting on December 17th, 2013 from 1-3pm EST. During this meeting, a transport overview for public health will be presented by Sandy Jones at CDC. Nagesh Bashyam, with the Office of the National Coordinator at DHHS, will present on Direct, which is a secure transport that EHR vendors are required to support for core objectives in MU. The Michigan Health Information Network has implemented Direct for MU and Jeff Livesay will present how they accomplished this successfully. During the last hour, Wendy Blumenthal with CDC will review the anticipated state MU workflow for receiving and processing cancer physician reports as part of MU Stage 2. She will also demonstrate the CDA Validation Plus software, provide updates on development of the eMaRC Plus Physician Reporting Module, and provide an overview on how CDC plans to provide MU technical assistance. Sandy Jones will review state responses received on the status of their respective MU activities.

Meaningful Use Town Hall 4 - June 4, 2013

The Centers for Disease Control and Prevention (CDC) invites you to participate in a Cancer Reporting Meaningful Use (MU) Town Hall Meeting on Tuesday, June 4th, 2013, from 3:00pm – 4:30pm ET. During this meeting we will review activities from the declaration process, registration of intent, on-boarding process, and acknowledgement for ongoing submission. The purpose of this review is to provide a clear overview of what is expected from all participating partners (Public Health Agency, State Cancer Registry, EHR Vendor, Physicians) and the order in which things should be completed.

Meaningful Use Town Hall 3 - April 18, 2013

The Centers for Disease Control and Prevention (CDC) invites you to participate in a Cancer Reporting Meaningful Use (MU) Town Hall Meeting on Thursday, April 18th, 2013, from 2:00pm – 3:30pm EDT. During this meeting a live demonstration of the current alpha version of the eMaRC Plus Physician Reporting Module will be shared. We will also review priorities for development of system capabilities for the beta release in September 2013.

Meaningful Use Town Hall 2 - March 1, 2013

The Centers for Disease Control and Prevention (CDC) held a Meaningful Use (MU) Town Hall Meeting with the cancer community on Friday, March 1st, 2013. This meeting provided information on activities for implementation of cancer reporting from Eligible Professional Electronic Health Records (EHRs) to state cancer registries as part of MU Stage 2. Several documents were reviewed and discussed during this call.

Meaningful Use Town Hall - March 19, 2012

The Centers for Medicare and Medicaid Services (CMS) and Office of the National Coordinator (ONC) Notices of Proposed Rule Making (NPRM) for Meaningful Use Stage 2 were officially released in the Federal Register on March 7th, 2012. The deadline for providing comments is May 7, 2012 at 5:00pm EDT. We hope that you will take the time to review and provide comments on the cancer reporting objective in the CMS NPRM, the cancer reporting standard in the ONC NPRM, and the Implementation Guide for Healthcare Provider Reporting to Central Cancer Registries referenced in the ONC NPRM and available on the CDC website. All comments must go through the comment process described in the NPRMs. A courtesy copy of your comments can be sent to CDC at cancerehrreporting@cdc.gov. Positive comments as well as constructive critique are welcomed.

To help provide registries with more information about these three documents, assist with navigation through them, and answer any technical questions, NAACCR and CDC held a Town Hall Meeting on March 19, 2012. A recording of the town hall, a copy of the slides presented, and the Q&A are posted below.